Besides being somewhat of a buzzword in many sectors, artificial intelligence (AI) in drug development shows the potential to ...

The Business Research Company's Early Year-End Sale! Get up to 30% off detailed market research reports-for a limited time only! Generative artificial intelligence (AI) in the pharmaceutical market ...

The current & future impact of AI on pharmaceutical R&DInsights from Norstella's 2024 AI survey Artificial intelligence (AI) ...

ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Growth Strategy” third quarter ...

AI and the pharmaceutical market are an ideal match. Drug discovery and development companies are burdened with intense competitive and financial pressure to shorten timelines and accelerate ...

NetraMark (CSE:AIAI), a micro-cap AI stock focused on optimizing clinical trials, has signed a pilot agreement with a ...

A new paradigm for developing talent The pharmaceutical industry's use of AI to revolutionise the healthcare sector brings with it a new paradigm for developing talent, which involves working ...

When looking ahead to 2025, Cramer noted a significant lack of consensus about future rate cuts. He pointed to Fed funds ...